Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
I-Mab Announces First Patient Dosed in China Phase 3 Study of Eftansomatropin Alfa in Pediatric Patients with Growth Hormone Deficiency 2021-02-25 21:00
I-Mab Announces Upcoming Participation at March Conferences 2021-02-24 21:00
Gracell Biotechnologies to Report Fourth Quarter and Fiscal 2020 Financial Results on Tuesday, March 9, 2021 2021-02-23 21:00
Positive BNC210 7-Day Dosing Pharmacokinetic Study Exceeds Blood Exposure Projected for Phase 2b PTSD Trial 2021-02-22 19:00
Completion of Patients' Recruitment for Proxalutamide's COVID-19 Hospitalised Study 2021-02-22 17:14
China SXT Pharmaceuticals, Inc. Announces 1 for 4 Reverse Share Split 2021-02-19 21:00
Psychobiotic PS128 consumption shows benefits to Parkinson's symptoms in new clinical study 2021-02-19 12:07
GenScript ProBio and Neoletix Announce Successful Completion of 200-Liter GMP Production Runs of Recombinant Coagulation FVIII Based on a Novel Production Technology 2021-02-18 22:00
Everest Medicines Appoints Kevin Guo as Chief Commercial Officer 2021-02-18 12:21
Joint feasibility assessment of Bionomics' BNC210 and EmpathBio's MDMA derivative EMP-01 treatment regimen for PTSD 2021-02-17 19:00
China SXT Pharmaceuticals, Inc. Enters into Non-Binding LOI to Acquire Jiangsu Renji Pharmaceutical Chain Co., Ltd. 2021-02-11 21:00
GenScript Receives FDA Emergency Use Authorization for Use of cPass(TM) SARS-CoV-2 Neutralization Antibody Test in Convalescent Plasma Screening 2021-02-11 20:30
Transcenta Holding Announces Appointment of Dr. Michael Shi as Executive Vice President, Head of Global R&D and Chief Medical Officer 2021-02-11 08:00
I-Mab Announces China NMPA Clearance for Phase 1 Study of TJ210/MOR210 in Patients with Advanced Solid Tumors 2021-02-10 21:00
Tessa Therapeutics Announces Successful Dosing of First Patient Cohort in Phase I Allogeneic Cell Therapy Trial 2021-02-10 19:12
$16 Million Capital Raise to Progress Bionomics BNC210 PTSD Trial 2021-02-10 19:00
Alterity Therapeutics announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson's disease clinical trials 2021-02-09 21:53
Registered Secondary Public Offering of American Depositary Shares by Certain Pre-IPO Shareholders of I-Mab Has Priced 2021-02-09 21:00
Proposed Registered Secondary Public Offering of American Depositary Shares by Certain Pre-IPO Shareholders of I-Mab 2021-02-06 06:27
I-Mab Announces Multiple Clinical Advancements of Its Differentiated CD73 Antibody Uliledlimab in China and the U.S. 2021-02-05 21:00
1 109 110 111 112 113 165